Angiotensin II type 1 receptor expression in human coronary arteries with variable degrees of atherosclerosis

[1]  柳谷 良裕.  Angiotensin II Type 1 Receptor-Mediated Peroxide Production in Human Macrophages , 2001 .

[2]  J. Mehta,et al.  Oxidized LDL Upregulates Angiotensin II Type 1 Receptor Expression in Cultured Human Coronary Artery Endothelial Cells: The Potential Role of Transcription Factor NF-&kgr;B , 2000, Circulation.

[3]  A Daugherty,et al.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.

[4]  K. Channon,et al.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.

[5]  R. Bohle,et al.  CD143 in the development of atherosclerosis. , 2000, Atherosclerosis.

[6]  C. Ferrario,et al.  Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. , 2000, Circulation.

[7]  John A. Wilson,et al.  Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. , 2000, Hypertension.

[8]  G. Nickenig,et al.  Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. , 1999, Circulation.

[9]  J. Holtz,et al.  Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. , 1999, Circulation.

[10]  J. Mehta,et al.  Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. , 1999, Circulation research.

[11]  D. Harrison,et al.  Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.

[12]  T. Ogihara,et al.  Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. , 1999, Journal of hypertension.

[13]  J F Cornhill,et al.  Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. , 1999, JAMA.

[14]  B. Berk,et al.  Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. , 1999, Journal of the American Society of Nephrology : JASN.

[15]  J. Mehta,et al.  Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Witztum,et al.  Angiotensin II Increases Macrophage-mediated Modification of Low Density Lipoprotein via a Lipoxygenase-dependent Pathway* , 1997, The Journal of Biological Chemistry.

[17]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[18]  J. Egido,et al.  Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. , 1997, Circulation.

[19]  G. Nickenig,et al.  Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. , 1997, Circulation.

[20]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.